S. Nanji

Real-World Effectiveness of Belimumab in Systemic Lupus Erythematosus: A Systematic Literature Review

C. Bell, S. Snedecor, Shirley P Huang, 2022, Rheumatology and Therapy.

Budget Impact Analysis of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Event

D. Lautsch, D. Patel, S. Nanji, 2021, Advances in Therapy.

Real-World Effectiveness of Belimumab in Systemic Lupus Erythematosus: A Systematic Literature Review

C. Bell, S. Snedecor, Shirley P Huang, 2022, Rheumatology and Therapy.

A Cost per Responder Model for Abatacept versus Adalimumab Among Rheumatoid Arthritis Patients with Seropositivity

D. Patel, S. Nanji, F. Lobo, 2020, ClinicoEconomics and outcomes research : CEOR.

CEOR_A_263903 589..594

D. Patel, S. Nanji, F. Lobo, 2020 .

An indirect comparison of 144-week efficacy, safety, and tolerability of dolutegravir plus lamivudine and second-generation integrase inhibitor–based, 3-drug, single-tablet regimens in therapy-naive people with HIV-1

L. Evitt, R. Grove, S. Snedecor, 2023, AIDS Research and Therapy.